Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Understand the criteria that trigger Enhanced Due Diligence in crypto platforms, including transaction patterns and risk indicators.
13,796 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Zevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Dive into cadre holdings (cdre) 2025 with a clear, practical lens. This guide translates earnings chatter into real-w...
U.S. equities drift lower as crude oil rises on geopolitical risk, pushing the S&P 500 lower while investors parse ea...
As AI workloads surge, memory players like MICRON TECHNOLOGY (MU) stand at a crossroads. This guide breaks down how g...
HeartBeam heads into 2025 earnings with a mix of potential breakthroughs and headwinds. This guide explains what the ...
MercadoLibre, the region’s tech and payments titan, has tumbled from its June peak but continues to post rapid revenu...
Iran’s warning for UAE ports marks a new chapter in the Gulf crisis, sending tremors through oil markets and regional...
Geopolitical tensions can rattle markets in the short term, but history favors patient investors. This guide explains...
Oil markets can surge, and prices near $100 tempting headlines pull investors toward energy stocks. This article expl...
Oil prices jumped above $100 a barrel as YieldMax’s XOMO ETF continued to pay weekly distributions fed by option prem...
Investors sent shares of National Energy Services Reunited higher after news of sizable cementing contracts in the Mi...